Clin2
NCT02647879Possibly a fitRecruiting

Preventing hepatitis C spread with treatment in Iceland

Hepatitis C

Part of Digestive system, Infections clinical trials.

This study looks at giving hepatitis C treatment to people who test positive, to help prevent the infection from spreading. If you are 18 or older, live in Iceland, and can consent, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years old or older
  • You must have a positive hepatitis C (HCV) test
  • You must live in Iceland
  • You must have Icelandic health insurance coverage
  • You must be able to sign (or give) informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05042544Recruiting
Testing program for people at risk of hepatitis C

This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.

Canberra, Australian Capital Territory
NCT06306300Recruiting· Phase 4
Hepatitis C treatment at local clinics vs standard care

This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.

Rio de Janeiro, Rio de Janeiro
NCT07040319Recruiting· Phase 1/Phase 2
Hepatitis C treatment study for pregnant women

This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.

Los Angeles, California
NCT05248919Enrolling by invitation
Study treatment for hepatitis C that did not work before

This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.

Karachi, Sindh
NCT06159504Recruiting· Early Phase 1
Simplifying Hepatitis C Care for People Who Inject Drugs

This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.

Yerevan
NCT07237282Not yet recruiting· Phase 1
Hepatitis C vaccine trial for healthy adults

This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.

Edmonton, Alberta

Hear when a new Hepatitis C trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.